Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Abbeha Talib: Balancing Stroke Prevention and Bleeding Risk After Successful AF Ablation
Abbeha Talib/LinkedIn
Jun 23, 2026, 14:15

Abbeha Talib: Balancing Stroke Prevention and Bleeding Risk After Successful AF Ablation

Abbeha Talib, Social Media Manager and Content Strategist at Medify HELP, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Cardiology in Review, adding:

“Excited to share that our latest work has been published in Cardiology in Review:

‘Discontinuation of Oral Anticoagulants After Successful Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis.’

What we explored:

In this large-scale analysis, we examined whether oral anticoagulation (OAC) can be safely discontinued after successful catheter ablation for atrial fibrillation (AF), comparing long-term outcomes of OAC discontinuation (OFF-OAC) versus continuation (ON-OAC).

Key findings: (29 studies, 153,352 participants):

  • No significant difference in thromboembolic risk with OAC discontinuation (OR: 0.91; P = 0.60)
  • OFF-OAC significantly reduced major bleeding risk by approximately 66 percent (OR: 0.34; P less than 0.00001)
  • No significant difference in all-cause mortality (OR: 0.67; P = 0.06)
  • OAC discontinuation was associated with significantly lower AF recurrence (OR: 0.57; P = 0.0003)

Subgroup insights:

  • Greater bleeding reduction with OAC discontinuation was observed in:
  • Warfarin users (OR: 0.13) versus warfarin/NOAC users (OR: 0.43)
  • Non-Asian cohorts (OR: 0.12) versus Asian cohorts (OR: 0.45)
  • Patients switched to antiplatelet therapy (OR: 0.18) versus those not switched (OR: 0.44)

Takeaway:

Discontinuing OAC after successful AF ablation significantly reduces major bleeding without increasing thromboembolic or mortality risk in appropriately selected patients.

OAC may be safely withdrawn in low-risk patients (CHA₂DS₂-VASc less than 2) with careful monitoring, while high-risk patients warrant individualized decision-making.

Grateful to my coauthors Muhammad Tahir, Muhammad Abdullah Naveed, Muhammad Hamza Khan, Muhammad Shaheer Hussain Qureshi, Susheeta Rani, Abdur Rafay Bilal, Muhammad Salik Khan, Shaheer Bin Shafiq, Ali A. Mithani, Saad Ahmed Waqas and mentors for their collaboration on this project.”

Title: Discontinuation of Oral Anticoagulants After Successful Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis

Authors: Tahir Muhammad, Naveed Muhammad Abdullah, Khan Muhammad Hamza, Qureshi Shaheer, Rani Susheeta, Bilal Abdur Rafay, Talib Abbeha, Uddin Muhammad Salik, Bin Shafiq Shaheer, Mithani, Ali A., Waqas Saad Ahmed

Abbeha Talib: Balancing Stroke Prevention and Bleeding Risk After Successful AF Ablation

Stay updated on all scientific advances with Hemostasis Today.

Abbeha Talib AF AF ablation Ali A. Bilal Abdur Rafay Bin Shafiq Shaheer Cardiology in Review Health Hematology Hemostasis Hemostasis News Hemostasis Today Khan Muhammad Hamza Medicine Mithani Naveed Muhammad Abdullah Qureshi Shaheer Rani Susheeta Tahir Muhammad Talib Abbeha Uddin Muhammad Salik Waqas Saad Ahmed
NewsFeed